Search Results

Mikart, LLC, a leading contract development and manufacturing organization, is thrilled to announce a significant milestone in its collaboration with Nano PharmaSolutions, Inc..

Mikart, LLC announces the addition of cutting-edge, Fette® double-sided tablet presses to bolster its production capacity and meet the product demands of its increasing number of clients.

Mikart, LLC is pleased to announce its recent acquisition of the state-of-the-art Flexpack NF-150 Horizontal Sachet-Packaging Machine.

Mikart, LLC (“Mikart”) a comprehensive contract development and manufacturing organization announced that it has entered into a collaboration agreement with Nano PharmaSolutions, Inc. (“NPS”), an innovative nanotechnology company that has a proprietary NanoTransformer™ that enhances the solubility of pharmaceutical active ingredients (API).

Mikart, LLC announced that it has entered into a collaboration agreement with Fluid Pharma Ltd, a technology licensing company, to advance the application of Fluid Pharma’s proprietary MicroCoat™ technology in new therapies for pediatric, geriatric, and oral liquid modified release applications, in North America.

◆Investment to support services growth. ◆Industry veterans join board of directors, including John Chickosky as Executive Chairman, and Greg Swanberg and Martin LeBlanc as Directors.

We are in an unprecedented time in neurotherapeutics. Medicines that address the causative disease biology underlying central nervous system